MicroSectors FANG and Innovation 3X Leveraged ETN vs Revolution Medicines Inc. Common Stock — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $36.81 (market cap $2.98B), while Revolution Medicines Inc. Common Stock trades at $191 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 13.5× MicroSectors FANG and Innovation 3X Leveraged ETN's market cap, and MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 19 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FNGU | RVMD | |
|---|---|---|
Market Cap | $2.98B | $40.32B |
Volume | 4,682,352 | 4,855,734 |
Sector | Leveraged / Inverse | Health |
52-Week High | $37.20 | $221.15 |
52-Week Low | $13.73 | $47.50 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | — | $37.02B |
Signals from Pluang's Aura AI — not financial advice
FNGU, a 3x leveraged ETN tracking major tech stocks, trades at $36.31, down 2.39% today. Technical indicators show a bullish trend with strong moving average support, while oscillators remain neutral. The ETN faces significant volatility risks, having lost 87% during previous tech sector downturns according to 247 Wallst analysis from August 19, 2026.
The outlook remains highly speculative given the leveraged structure. While bullish technicals suggest near-term upside potential to resistance at $37-39, the extreme volatility and concentration in mega-cap tech stocks present substantial downside risks during market corrections. Investors require high risk tolerance for this instrument.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →